FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/8/2026
Charles River Laboratories (NYSE: CRL) reported Q1 EPS of $0.82, $0.08 better than the analyst estimate of $0.74. Revenue for the quarter came in at $299.4 million versus the consensus estimate of $302.08 million.
Charles River Laboratories sees FY2014 EPS of $3.15 - $3.25, versus prior guidance of $.00 - $3.10.... More

